adolescents: A cognitive-behavioral treatment manual. New York: Guilford Press.

March, J., Mulle, K., & Herbel, B. (1994). Behavioral psychotherapy for children and adolescents with obsessive-compulsive disorder: an open trial of a new protocol driven treatment package. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 333–341.

March, J. S., Parker, J. D. A., Sullivan, K., & Stallings, P. (1997). The Multidimensional Anxiety Scale for Children (MASC): Factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 554–564.

Marks, I. (1986). Genetics of fear and anxiety disorders [review]. British Journal of Psychiatry, 149, 408–418.

Marks, I. M. (1987). Fears, phobias, and rituals. New York: Oxford University Press.

Marks, I. M., Lelliott, P. T., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., et al. (1988). Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals. British Journal of Psychiatry, 152, 522–534.

Marks, I., Lovell, K., Noshirvani, H., Livanou, M., & Thrasher, S. (1998). Treatment of posttraumatic stress disorder by exposure and/or cognitive restructuring: A controlled study. Archives of General Psychiatry, 55, 317–325. 

Marks, I. M., Swinson, R. P., Basoglu, M., Kuch K., Noshirvani, H., O'Sullivan, G., et al. (1993). Alprazolam and exposure alone and combined in panic disorder with agoraphobia: A controlled study in London and Toronto. British Journal of Psychiatry, 162, 776–787.

Marlatt, G. A., & Gordon, J. J. (1985). Relapse prevention. New York: Guilford Press.

Marshall, R. D., Beebe, K. L., Oldhan, M., & Zaninelli, R. (2001). Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. American Journal of Psychiatry, 158, 1982–1988. 

Martenyi, F., Brown, E. B., Zhang, H., Koke, S. C., & Prakash, A. (2002a). Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder. British Journal of Psychiatry, 181, 315–320. 

Martenyi, F., Brown, E. B., Zhang, H., Prakash, A., & Koke, S. C. (2002b). Fluoxetine versus placebo in posttraumatic stress disorder. Journal of Clinical Psychiatry, 63, 199–206.

Martin, M., Horder, P., & Jones, G. V. (1992). Integral bias in naming of phobia-related words. Cognition and Emotion, 6, 479–486.

Martin, M., & Jones, G. V. (1995). Integral bias in the cognitive processing of emotionally linked pictures. British Journal of Psychology, 86, 419–435.

Masia, C. L., Klein, R. G., Storch, E. A., & Corda, B. (2001). School-based behavioral treatment for social anxiety disorder in adolescents: Results of a pilot study. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 780–786. 

Mathew, S. J., Coplan, J. D., & Gorman, J. M. (2001). Management of treatment-refractory panic disorder. Psychopharmacology Bulletin, 35, 97–110.

Mattis, S. G., Hoffman, E. C., Cohen, E. M., Pincus, D. B., Choate, M. L., & Micco, J. A. (2001). Cognitive-behavioral treatment of panic disorder in adolescence. In C. L. Masia & E. A. Storch (Chairs), Treatment of childhood anxiety: Innovative interventions and future directions. Symposium presented at the meeting of the Anxiety Disorders Association of America, Atlanta, Georgia.

Mattis, S. G., & Ollendick, T. H. (2002). School refusal and separation anxiety. In M. Hersen (Ed.), Clinical behavior therapy: Adults and children (pp. 304–325). New York: John Wiley & Sons.

Mavissakalian, M. R., & Perel, J. M. (1992). Clinical experiments in maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobia. Archives of General Psychiatry, 49, 318–323.

Mavissakalian, M. R., & Perel, J. M. (2001). 2nd year maintenance and discontinuation of imipramine in panic disorder with agoraphobia. Annals of Clinical Psychiatry, 13, 63–67. 

Mayou, R., Bryant, B., & Ehlers, A. (2001). Prediction of psychological outcomes one year after a motor vehicle accident. American Journal of Psychiatry, 158, 1231–1238. 

Mayou, R. A., Gill, D., Thompson, D. R., Day, A., Hicks, N., Volmink, J., et al. (2000). Depression and anxiety as predictors of outcome after myocardial infarction. Psychosomatic Medicine, 62, 212–219.

McCracken, J. T., Walkup, J. T., & Koplewicz, H. S. (2002). Childhood and early-onset anxiety: Treatment and biomarker studies. Journal of Clinical Psychiatry, 63, 8–11.

McDougle, C. J., Epperson, C. N., Pelton, G. H., Wasylink, S., & Price, L. H. (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives General Psychiatry, 57, 794–801. 

McDougle, C. J., Fleischmann, R. L., Epperson,